Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26FY8FK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,527
Award facts
- Contract value 100% obligated
- $39,527.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,527.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on November 18, 2025, with completion targeted for November 19, 2025. This non-set-aside competitive award is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this supply requirement as part of its extensive portfolio of delivery orders with the Defense Logistics Agency's Medical Supply Chain. The company's SPE2DX IDC encompasses a broad range of pharmaceutical products and medical supplies including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Cosentyx delivery order aligns with DLA's continued reliance on AmerisourceBergen as a primary pharmaceutical supplier supporting military medical readiness and veteran healthcare needs.
Quick answers
Who was awarded contract SPE2DR26FY8FK?
SPE2DR26FY8FK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FY8FK worth?
The government has obligated $39,527 on SPE2DR26FY8FK.
Is contract SPE2DR26FY8FK an order under another contract?
Yes. SPE2DR26FY8FK is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8FK competed?
The extent of competition for SPE2DR26FY8FK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award